Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Blood Cancer Journal
|
February 15, 2018
Chronic neutrophilic leukemia: new science and new diagnostic criteria
Natasha Szuber, Ayalew Tefferi
Current Treatment Options in Oncology
|
June 7, 2021
Current Management of Chronic Neutrophilic Leukemia
Natasha Szuber, Ayalew Tefferi
Current Opinion in Hematology
|
December 20, 2017
Driver mutations in primary myelofibrosis and their implications
Natasha Szuber, Ayalew Tefferi
Journal of Clinical Pathology
|
July 29, 2016
Novel germline mutations in the calreticulin gene: implications for the diagnosis of myeloproliferative neoplasms
Natasha Szuber, Bruno Lamontagne, Lambert Busque
American Journal of Hematology
|
March 26, 2023
JAK2 unmutated erythrocytosis: 2023 Update on diagnosis and management
Naseema Gangat, Natasha Szuber, Ayalew Tefferi
Hematology. American Society of Hematology. Education Program
|
December 5, 2025
JAK2 wild-type erythrocytosis: concept, differential diagnosis, diagnostic steps, and treatment approaches
Natasha Szuber, Ayalew Tefferi, Naseema Gangat
American Journal of Hematology
|
April 22, 2024
Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management
Natasha Szuber, Attilio Orazi, Ayalew Tefferi
American Journal of Hematology
|
November 27, 2019
Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management
Natasha Szuber, Michelle Elliott, Ayalew Tefferi
American Journal of Hematology
|
January 28, 2022
Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management
Natasha Szuber, Michelle Elliott, Ayalew Tefferi
American Journal of Hematology
|
October 22, 2025
JAK2 Unmutated Erythrocytosis: 2026 Update on Diagnosis and Management
Naseema Gangat, Natasha Szuber, Ayalew Tefferi
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Blood Cancer Journal
|
February 15, 2018
Chronic neutrophilic leukemia: new science and new diagnostic criteria
Natasha Szuber, Ayalew Tefferi
Current Treatment Options in Oncology
|
June 7, 2021
Current Management of Chronic Neutrophilic Leukemia
Natasha Szuber, Ayalew Tefferi
Current Opinion in Hematology
|
December 20, 2017
Driver mutations in primary myelofibrosis and their implications
Natasha Szuber, Ayalew Tefferi
Journal of Clinical Pathology
|
July 29, 2016
Novel germline mutations in the calreticulin gene: implications for the diagnosis of myeloproliferative neoplasms
Natasha Szuber, Bruno Lamontagne, Lambert Busque
American Journal of Hematology
|
March 26, 2023
JAK2 unmutated erythrocytosis: 2023 Update on diagnosis and management
Naseema Gangat, Natasha Szuber, Ayalew Tefferi
Hematology. American Society of Hematology. Education Program
|
December 5, 2025
JAK2 wild-type erythrocytosis: concept, differential diagnosis, diagnostic steps, and treatment approaches
Natasha Szuber, Ayalew Tefferi, Naseema Gangat
American Journal of Hematology
|
April 22, 2024
Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management
Natasha Szuber, Attilio Orazi, Ayalew Tefferi
American Journal of Hematology
|
November 27, 2019
Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management
Natasha Szuber, Michelle Elliott, Ayalew Tefferi
American Journal of Hematology
|
January 28, 2022
Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management
Natasha Szuber, Michelle Elliott, Ayalew Tefferi
American Journal of Hematology
|
October 22, 2025
JAK2 Unmutated Erythrocytosis: 2026 Update on Diagnosis and Management
Naseema Gangat, Natasha Szuber, Ayalew Tefferi
Page
of 4